Company / Income Tax
Day One Biopharmaceuticals, Inc. Income Tax History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-$2.0M
FY2025
5-year range
-$2.0M / $7.1M
FY2022-FY2025
Trend
-127.7%
vs FY2024
Sector context
#182 of 202
Health Care
What the data says
Among 202 Health Care companies, Day One Biopharmaceuticals, Inc. is in the top 10% for income tax. Improved from $0 to -$2M over the past 2 years.
Based on SEC 10-K filings.
-$2M in FY2025.
Improved from $0 to -$2M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 202This company -$2.0M Sector average $119.7M
▼
-101.7% below sector average
Key checks
Key Insights
- In FY2025, income tax decreased 127.7% year-over-year.
- Ranks #182 out of 202 companies in the Health Care sector.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.0M | -127.7% |
| FY2024 | $7.1M | - |
| FY2023 | $0 | - |
| FY2022 | $0 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026